Completed
Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection
NCT04019717
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
- Locations
-
- Clinical Trial Site Antwerp, Belgium
- Clinical Trial Site Phoenix, Mauritius
- Clinical Trial Site Chisinau, Moldova